StockData
OPRXNasdaqServices-Business Services, NECFiscal year ends December 31

OptimizeRx Corp

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$8.74+0.24 (+2.82%)

Close on Oct 19, 2026

Market cap
$164.19M
P/E (TTM)
36.4
Dividend yield
–

OptimizeRx Corp revenue by segment

No segment breakdown reported

OptimizeRx does not break out revenue by segment, region or product in the tagged data of its filings for this period type.